Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
642 studies found for:    lupus
Show Display Options
RSS Create an RSS feed from your search for:
lupus
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire
Condition: Lupus
Interventions: Other: SLA Questionnaire;   Other: Lupus Qol Questionnaire
2 Recruiting The Effect of Metformin on Reducing Lupus Flares
Condition: Systemic Lupus Erythematosus
Interventions: Drug: metformin;   Drug: placebo
3 Completed CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)
Condition: Systemic Lupus Erythematosus
Intervention:
4 Completed Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus Patients
Condition: Lupus Erythematosus, Systemic
Intervention: Other: Ultrasonography
5 Completed Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Condition: Lupus Nephritis
Intervention:
6 Completed Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus
Condition: Subacute Cutaneous Lupus Erythematosus
Interventions: Drug: KRP203 - 1.2mg;   Drug: Placebo to KRP203 - 1.2 mg
7 Completed
Has Results
Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Intervention: Behavioral: Cutaneous Lupus educational script
8 Completed
Has Results
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Intervention: Drug: IVIg
9 Terminated Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: TRU-015
10 Terminated Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus
Condition: Cutaneous Lupus Erythematosus
Intervention: Dietary Supplement: vitamin D
11 Completed Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis
Conditions: SLE;   Lupus Nephritis;   Renal Insufficiency;   End-stage Renal Disease
Interventions: Drug: Tacrolimus;   Drug: cyclophosphamide
12 Completed Balancing Lupus Experiences With Stress Strategies
Condition: Systemic Lupus Erythematosus
Intervention: Behavioral: Arthritis Self Management Program
13 Recruiting Weaning of Immunosuppression in Nephritis of Lupus
Condition: Nephritis of Lupus
Interventions: Drug: mycophenolate mofetil or azathioprine;   Other: immunosuppressive treatment discontinuation
14 Completed A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus
Conditions: Metabolic Syndrome;   Cardiovascular Risk Factors;   Systemic Lupus Erythematosus
Intervention:
15 Completed Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors
Condition: Systemic Lupus Erythematosus
Intervention: Drug: atorvastatin
16 Completed Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus
Interventions: Drug: Pimecrolimus 1% cream;   Drug: betamethasone valerate 0.1% cream
17 Enrolling by invitation European Society of Cutaneous Lupus Erythematosus (EUSCLE)
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic
Intervention: Procedure: laboratory analysis
18 Not yet recruiting Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)
Conditions: Anti-Phospholipids Syndrome (APS);   Systemic Lupus Erythematosus (SLE)
Intervention:
19 Withdrawn Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Rituximab
20 Recruiting Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Tacrolimus vs. Mycophenolate mofetil for Induction Therapy in Lupus Nephritis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.